ampka Search Results


rabbit polyclonal antibodies to phospho-acc  (Upstate Biotechnology Inc)
90
Upstate Biotechnology Inc rabbit polyclonal antibodies to phospho-acc
Rabbit Polyclonal Antibodies To Phospho Acc, supplied by Upstate Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal antibodies to phospho-acc/product/Upstate Biotechnology Inc
Average 90 stars, based on 1 article reviews
rabbit polyclonal antibodies to phospho-acc - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-ampka  (ABclonal Biotechnology)
90
ABclonal Biotechnology anti-ampka
Anti Ampka, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-ampka/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
anti-ampka - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
adenovirus expressing a dominant negative form of the ampka subunit  (Eton Bioscience)
90
Eton Bioscience adenovirus expressing a dominant negative form of the ampka subunit
Adenovirus Expressing A Dominant Negative Form Of The Ampka Subunit, supplied by Eton Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adenovirus expressing a dominant negative form of the ampka subunit/product/Eton Bioscience
Average 90 stars, based on 1 article reviews
adenovirus expressing a dominant negative form of the ampka subunit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
adenosine 5'-monophosphate (amp)-activated protein kinase (ampka)2 knockout mice  (Cyagen Biosciences)
90
Cyagen Biosciences adenosine 5'-monophosphate (amp)-activated protein kinase (ampka)2 knockout mice
Adenosine 5' Monophosphate (Amp) Activated Protein Kinase (Ampka)2 Knockout Mice, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adenosine 5'-monophosphate (amp)-activated protein kinase (ampka)2 knockout mice/product/Cyagen Biosciences
Average 90 stars, based on 1 article reviews
adenosine 5'-monophosphate (amp)-activated protein kinase (ampka)2 knockout mice - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
raybiotech-specific elisa kit  (RayBiotech inc)
90
RayBiotech inc raybiotech-specific elisa kit
Pentoxifylline stimulated hepatic adenosine-monophosphate-activated protein kinase/mechanistic target of <t>rapamycin</t> <t>(AMPK/mTOR)</t> pathway in doxorubicin-intoxicated rats. Pentoxifylline (PTX; 100 mg/kg) was orally received daily, while doxorubicin (DOX; 18 mg/kg total cumulative dose; 3 mg/kg dose weekly) was received by the intraperitoneal route. The treatments were administered for 6 weeks. Herein, the protein expression of hepatic p-AMPK(Ser487), total AMPK, p-mTOR(Ser2448), and total mTOR was determined by <t>ELISA.</t> In the hepatic tissue of DOX-intoxicated rats, PTX resulted in an elevated p-AMPK(Ser487)/AMPK ratio ( A ) and diminished p-mTOR(Ser2448)/mTOR ratio ( B ). For n = 6, the values were shown as mean ± S.E.M. * p < 0.05, *** p < 0.001, or **** p < 0.0001 vs. control; # p < 0.05, ## p < 0.01 vs. DOX group. PTX, pentoxifylline; DOX, doxorubicin.
Raybiotech Specific Elisa Kit, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/raybiotech-specific elisa kit/product/RayBiotech inc
Average 90 stars, based on 1 article reviews
raybiotech-specific elisa kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rabbit anti-p-ampka (ser485  (ABclonal Biotechnology)
90
ABclonal Biotechnology rabbit anti-p-ampka (ser485
Pentoxifylline stimulated hepatic adenosine-monophosphate-activated protein kinase/mechanistic target of <t>rapamycin</t> <t>(AMPK/mTOR)</t> pathway in doxorubicin-intoxicated rats. Pentoxifylline (PTX; 100 mg/kg) was orally received daily, while doxorubicin (DOX; 18 mg/kg total cumulative dose; 3 mg/kg dose weekly) was received by the intraperitoneal route. The treatments were administered for 6 weeks. Herein, the protein expression of hepatic p-AMPK(Ser487), total AMPK, p-mTOR(Ser2448), and total mTOR was determined by <t>ELISA.</t> In the hepatic tissue of DOX-intoxicated rats, PTX resulted in an elevated p-AMPK(Ser487)/AMPK ratio ( A ) and diminished p-mTOR(Ser2448)/mTOR ratio ( B ). For n = 6, the values were shown as mean ± S.E.M. * p < 0.05, *** p < 0.001, or **** p < 0.0001 vs. control; # p < 0.05, ## p < 0.01 vs. DOX group. PTX, pentoxifylline; DOX, doxorubicin.
Rabbit Anti P Ampka (Ser485, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-p-ampka (ser485/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
rabbit anti-p-ampka (ser485 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
sirna targeting ampka  (Genechem)
90
Genechem sirna targeting ampka
Pentoxifylline stimulated hepatic adenosine-monophosphate-activated protein kinase/mechanistic target of <t>rapamycin</t> <t>(AMPK/mTOR)</t> pathway in doxorubicin-intoxicated rats. Pentoxifylline (PTX; 100 mg/kg) was orally received daily, while doxorubicin (DOX; 18 mg/kg total cumulative dose; 3 mg/kg dose weekly) was received by the intraperitoneal route. The treatments were administered for 6 weeks. Herein, the protein expression of hepatic p-AMPK(Ser487), total AMPK, p-mTOR(Ser2448), and total mTOR was determined by <t>ELISA.</t> In the hepatic tissue of DOX-intoxicated rats, PTX resulted in an elevated p-AMPK(Ser487)/AMPK ratio ( A ) and diminished p-mTOR(Ser2448)/mTOR ratio ( B ). For n = 6, the values were shown as mean ± S.E.M. * p < 0.05, *** p < 0.001, or **** p < 0.0001 vs. control; # p < 0.05, ## p < 0.01 vs. DOX group. PTX, pentoxifylline; DOX, doxorubicin.
Sirna Targeting Ampka, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sirna targeting ampka/product/Genechem
Average 90 stars, based on 1 article reviews
sirna targeting ampka - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
antisera against ampka  (Zeneca Ltd)
90
Zeneca Ltd antisera against ampka
Pentoxifylline stimulated hepatic adenosine-monophosphate-activated protein kinase/mechanistic target of <t>rapamycin</t> <t>(AMPK/mTOR)</t> pathway in doxorubicin-intoxicated rats. Pentoxifylline (PTX; 100 mg/kg) was orally received daily, while doxorubicin (DOX; 18 mg/kg total cumulative dose; 3 mg/kg dose weekly) was received by the intraperitoneal route. The treatments were administered for 6 weeks. Herein, the protein expression of hepatic p-AMPK(Ser487), total AMPK, p-mTOR(Ser2448), and total mTOR was determined by <t>ELISA.</t> In the hepatic tissue of DOX-intoxicated rats, PTX resulted in an elevated p-AMPK(Ser487)/AMPK ratio ( A ) and diminished p-mTOR(Ser2448)/mTOR ratio ( B ). For n = 6, the values were shown as mean ± S.E.M. * p < 0.05, *** p < 0.001, or **** p < 0.0001 vs. control; # p < 0.05, ## p < 0.01 vs. DOX group. PTX, pentoxifylline; DOX, doxorubicin.
Antisera Against Ampka, supplied by Zeneca Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antisera against ampka/product/Zeneca Ltd
Average 90 stars, based on 1 article reviews
antisera against ampka - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ampka activator (5-aminoimidazole-4-carboxamide-1b-d-ribofuranoside; aicar)  (clea japan inc)
90
clea japan inc ampka activator (5-aminoimidazole-4-carboxamide-1b-d-ribofuranoside; aicar)
Pentoxifylline stimulated hepatic adenosine-monophosphate-activated protein kinase/mechanistic target of <t>rapamycin</t> <t>(AMPK/mTOR)</t> pathway in doxorubicin-intoxicated rats. Pentoxifylline (PTX; 100 mg/kg) was orally received daily, while doxorubicin (DOX; 18 mg/kg total cumulative dose; 3 mg/kg dose weekly) was received by the intraperitoneal route. The treatments were administered for 6 weeks. Herein, the protein expression of hepatic p-AMPK(Ser487), total AMPK, p-mTOR(Ser2448), and total mTOR was determined by <t>ELISA.</t> In the hepatic tissue of DOX-intoxicated rats, PTX resulted in an elevated p-AMPK(Ser487)/AMPK ratio ( A ) and diminished p-mTOR(Ser2448)/mTOR ratio ( B ). For n = 6, the values were shown as mean ± S.E.M. * p < 0.05, *** p < 0.001, or **** p < 0.0001 vs. control; # p < 0.05, ## p < 0.01 vs. DOX group. PTX, pentoxifylline; DOX, doxorubicin.
Ampka Activator (5 Aminoimidazole 4 Carboxamide 1b D Ribofuranoside; Aicar), supplied by clea japan inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ampka activator (5-aminoimidazole-4-carboxamide-1b-d-ribofuranoside; aicar)/product/clea japan inc
Average 90 stars, based on 1 article reviews
ampka activator (5-aminoimidazole-4-carboxamide-1b-d-ribofuranoside; aicar) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ampka sirna  (Shanghai GenePharma)
90
Shanghai GenePharma ampka sirna
Pentoxifylline stimulated hepatic adenosine-monophosphate-activated protein kinase/mechanistic target of <t>rapamycin</t> <t>(AMPK/mTOR)</t> pathway in doxorubicin-intoxicated rats. Pentoxifylline (PTX; 100 mg/kg) was orally received daily, while doxorubicin (DOX; 18 mg/kg total cumulative dose; 3 mg/kg dose weekly) was received by the intraperitoneal route. The treatments were administered for 6 weeks. Herein, the protein expression of hepatic p-AMPK(Ser487), total AMPK, p-mTOR(Ser2448), and total mTOR was determined by <t>ELISA.</t> In the hepatic tissue of DOX-intoxicated rats, PTX resulted in an elevated p-AMPK(Ser487)/AMPK ratio ( A ) and diminished p-mTOR(Ser2448)/mTOR ratio ( B ). For n = 6, the values were shown as mean ± S.E.M. * p < 0.05, *** p < 0.001, or **** p < 0.0001 vs. control; # p < 0.05, ## p < 0.01 vs. DOX group. PTX, pentoxifylline; DOX, doxorubicin.
Ampka Sirna, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ampka sirna/product/Shanghai GenePharma
Average 90 stars, based on 1 article reviews
ampka sirna - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rabbit monoclonal anti-human ampka  (Beyotime)
90
Beyotime rabbit monoclonal anti-human ampka
Pentoxifylline stimulated hepatic adenosine-monophosphate-activated protein kinase/mechanistic target of <t>rapamycin</t> <t>(AMPK/mTOR)</t> pathway in doxorubicin-intoxicated rats. Pentoxifylline (PTX; 100 mg/kg) was orally received daily, while doxorubicin (DOX; 18 mg/kg total cumulative dose; 3 mg/kg dose weekly) was received by the intraperitoneal route. The treatments were administered for 6 weeks. Herein, the protein expression of hepatic p-AMPK(Ser487), total AMPK, p-mTOR(Ser2448), and total mTOR was determined by <t>ELISA.</t> In the hepatic tissue of DOX-intoxicated rats, PTX resulted in an elevated p-AMPK(Ser487)/AMPK ratio ( A ) and diminished p-mTOR(Ser2448)/mTOR ratio ( B ). For n = 6, the values were shown as mean ± S.E.M. * p < 0.05, *** p < 0.001, or **** p < 0.0001 vs. control; # p < 0.05, ## p < 0.01 vs. DOX group. PTX, pentoxifylline; DOX, doxorubicin.
Rabbit Monoclonal Anti Human Ampka, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit monoclonal anti-human ampka/product/Beyotime
Average 90 stars, based on 1 article reviews
rabbit monoclonal anti-human ampka - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
antibody to phospho-ampk (thr172)  (ZenBio)
90
ZenBio antibody to phospho-ampk (thr172)
Pentoxifylline stimulated hepatic adenosine-monophosphate-activated protein kinase/mechanistic target of <t>rapamycin</t> <t>(AMPK/mTOR)</t> pathway in doxorubicin-intoxicated rats. Pentoxifylline (PTX; 100 mg/kg) was orally received daily, while doxorubicin (DOX; 18 mg/kg total cumulative dose; 3 mg/kg dose weekly) was received by the intraperitoneal route. The treatments were administered for 6 weeks. Herein, the protein expression of hepatic p-AMPK(Ser487), total AMPK, p-mTOR(Ser2448), and total mTOR was determined by <t>ELISA.</t> In the hepatic tissue of DOX-intoxicated rats, PTX resulted in an elevated p-AMPK(Ser487)/AMPK ratio ( A ) and diminished p-mTOR(Ser2448)/mTOR ratio ( B ). For n = 6, the values were shown as mean ± S.E.M. * p < 0.05, *** p < 0.001, or **** p < 0.0001 vs. control; # p < 0.05, ## p < 0.01 vs. DOX group. PTX, pentoxifylline; DOX, doxorubicin.
Antibody To Phospho Ampk (Thr172), supplied by ZenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody to phospho-ampk (thr172)/product/ZenBio
Average 90 stars, based on 1 article reviews
antibody to phospho-ampk (thr172) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Pentoxifylline stimulated hepatic adenosine-monophosphate-activated protein kinase/mechanistic target of rapamycin (AMPK/mTOR) pathway in doxorubicin-intoxicated rats. Pentoxifylline (PTX; 100 mg/kg) was orally received daily, while doxorubicin (DOX; 18 mg/kg total cumulative dose; 3 mg/kg dose weekly) was received by the intraperitoneal route. The treatments were administered for 6 weeks. Herein, the protein expression of hepatic p-AMPK(Ser487), total AMPK, p-mTOR(Ser2448), and total mTOR was determined by ELISA. In the hepatic tissue of DOX-intoxicated rats, PTX resulted in an elevated p-AMPK(Ser487)/AMPK ratio ( A ) and diminished p-mTOR(Ser2448)/mTOR ratio ( B ). For n = 6, the values were shown as mean ± S.E.M. * p < 0.05, *** p < 0.001, or **** p < 0.0001 vs. control; # p < 0.05, ## p < 0.01 vs. DOX group. PTX, pentoxifylline; DOX, doxorubicin.

Journal: Pharmaceuticals

Article Title: Activation of AMPK/mTOR-Driven Autophagy and Suppression of the HMGB1/TLR4 Pathway with Pentoxifylline Attenuates Doxorubicin-Induced Hepatic Injury in Rats

doi: 10.3390/ph17060681

Figure Lengend Snippet: Pentoxifylline stimulated hepatic adenosine-monophosphate-activated protein kinase/mechanistic target of rapamycin (AMPK/mTOR) pathway in doxorubicin-intoxicated rats. Pentoxifylline (PTX; 100 mg/kg) was orally received daily, while doxorubicin (DOX; 18 mg/kg total cumulative dose; 3 mg/kg dose weekly) was received by the intraperitoneal route. The treatments were administered for 6 weeks. Herein, the protein expression of hepatic p-AMPK(Ser487), total AMPK, p-mTOR(Ser2448), and total mTOR was determined by ELISA. In the hepatic tissue of DOX-intoxicated rats, PTX resulted in an elevated p-AMPK(Ser487)/AMPK ratio ( A ) and diminished p-mTOR(Ser2448)/mTOR ratio ( B ). For n = 6, the values were shown as mean ± S.E.M. * p < 0.05, *** p < 0.001, or **** p < 0.0001 vs. control; # p < 0.05, ## p < 0.01 vs. DOX group. PTX, pentoxifylline; DOX, doxorubicin.

Article Snippet: The hepatic content of p-AMPK and total AMPK was measured using a RayBiotech-specific ELISA kit (Norcross, GA, USA; Cat. No. PEL-AMPKA-S487-T), as recommended by the vendor.

Techniques: Expressing, Enzyme-linked Immunosorbent Assay